ACCP Advocacy In Action

Advocacy Newsletter
ACCP News

NIH Releases New Version of the COVID-19 Treatment Guidelines Mar 08, 2023
GTMRx Welcomes America’s Physician Groups to Board of Directors Mar 03, 2023
From the Desk of the ACCP President Feb 27, 2023
ACCP Calls for Significant Structural Reforms to Medicare Part D MTM Feb 17, 2023
ACCP Advocates for Clinical Pharmacists in Outreach to Biden Administration Jan 27, 2023
NIH Releases Updates on Use of Bebtelovimab Dec 29, 2022
ACCP Joins Pharmacy Colleagues Calling on CMS to Clarify Guidance on Payment for Pharmacists’ Clinical Services Under the PREP Act Dec 16, 2022
From the Desk of the ACCP President Dec 12, 2022
NIH Releases New Statement on Bebtelovimab Dec 07, 2022
NIH Releases Major Update to the COVID-19 Treatment Guidelines Dec 01, 2022
SAP Posttest Deadlines Extended Nov 16, 2022
From the Desk of the ACCP Past President... Oct 20, 2022
NIH Releases New Statement on Omicron Subvariants and Anti-SARS-CoV-2 Monoclonal Antibodies Oct 19, 2022
Creating an Inclusive Culture at ACCP: Membership Votes to Approve Amendment to Bylaws Oct 17, 2022
NIH Publishes New Version of COVID-19 Treatment Guidelines Sep 26, 2022
From the Desk of the ACCP President Sep 06, 2022
Pharmacotherapy Publishes Consensus Recommendations for Use of Maintenance Immunosuppression in Solid Organ Transplantation Aug 30, 2022
Information about an Upcoming Special Vote on a Proposed Amendment to the ACCP Bylaws Aug 26, 2022
NIH Publishes COVID-19 Treatment Guidelines Update on Anti-SARS-CoV-2 Monoclonal Antibodies Aug 19, 2022
INFORMATION FOR ACCP MEMBERS: Monkeypox Vaccination/Treatment and Call for Clinician Input Aug 19, 2022
Major Update to COVID-19 Treatment Guidelines Released Aug 09, 2022
Hernandez Selected as Sixth NAM Fellow in Pharmacy Aug 09, 2022
ACCP Joins Multi-Stakeholder Advocacy Effort to Strengthen Nation’s Public Health Preparedness Aug 08, 2022
Pfizer Releases DHCP Letter and Updated Fact Sheet to Minimize Paxlovid Wrong Dose Medication Errors Aug 08, 2022
BPS Extends Deadline for Applications for 2022-2023 PGY2 Pharmacy Residency Research Grants Aug 08, 2022
Call for Applications: 2023-2024 ACCP Professional Leadership APPE Aug 01, 2022
GTMRx Provides Information to HHS on Initiative to Strengthen Primary Care Aug 01, 2022
From the Desk of the ACCP President Jul 05, 2022
Pharmacotherapy’s Impact Factor Increased to 6.251! Jun 28, 2022
ACCP Responds to CDC and ACIP on COVID-19 Vaccine Recommendation in Children 6 Months and Up Jun 21, 2022
New Version of the COVID-19 Treatment Guidelines Released Jun 01, 2022
NIH Panel Updates COVID-19 Treatment Guidelines May 16, 2022
ACCP Urges Passage of Legislation Covering Clinical Pharmacist Consultations May 12, 2022
NIH Panel Issues April 29 Update to COVID-19 Treatment Guidelines Apr 29, 2022
ACCP Authors Issue Brief on Comprehensive Medication Management for Substance Use Disorder in the Addiction Recovery Medical Home Apr 26, 2022
ACCP Joins Pharmacy-Wide Outreach to White House COVID-19 Response Coordinator Apr 20, 2022
COVID-19 Treatment Guidelines Remove Sotrovimab Recommendation Apr 08, 2022
Sotrovimab Recommendation Revised in COVID-19 Treatment Guidelines Apr 01, 2022
ACCP Joins 28 State & National Pharmacy Organizations Urging Congress to Fully Fund the COVID-19 Uninsured Program Mar 31, 2022

Cookies